NF‐κB expression levels are known to steadily increase as cancer progresses,26, 39, 44 but no prior study has examined the association of NF‐κB expression in benign prostate and subsequent prostate cancer risk. This evidence concerns the gene NFKB1 and prostate carcinoma.